Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BioTek Instruments and Global Cell Solutions Collaborate at LabAutomation2010

Published: Friday, January 29, 2010
Last Updated: Friday, January 29, 2010
Bookmark and Share
Collaborators announce a new poster detailing the use of BioTek’s microplate instrumentation for various cell-based assays.

BioTek Instruments, Inc., and Global Cell Solutions, Inc., (GCS) announce a formal collaboration for the coming year at LabAutomation 2010.

The poster Automation of a Microplate Cell-based Assay to Measure Activity of the Histamine H1 G Protein-coupled Receptor Using a Novel 3-D Cell Culture Technique is the first in a series of collaborative publications detailing the use of BioTek’s microplate instrumentation for various cell-based assays.

The application poster details the use of BioTek’s MicroFlo™ Select Dispenser, Precision™ Automated Microplate Pipetting System and Synergy™ 4 Multi-Mode Microplate Reader with a novel 3-D cell culture method and FRET-based assay to measure activity of a Histamine H1 G protein-coupled Receptor. BioTek used the BioLevitator™ and GEM™ technologies to provide transformed cell types.

BioTek’s MicroFlo™ Select and Precision will be at booth 151 along with the successor to Synergy™ 4 and latest microplate technology – the Synergy™ H4 Hybrid Microplate Reader. The new Synergy™ H4 combines high-performance filter-based detection and flexible monochromator-based detection in one compact instrument. This hybrid of both technologies provides for endless flexibility in current and future microplate-based assay choice.

This collaboration is an opportunity to explore new paradigms for cell-based assay workflows and microplate-based screening of 3-D cell cultures. “Customers are using BioTek’s plate readers for cell-based assays to an increasing extent,” explains Peter Banks, Scientific Director at BioTek Instruments.

“We are particularly interested in collaborating with companies that provide novel enabling technologies such as the BioLevitator and GEM technologies for improving cell-based assay workflows. Being able to dispense cells directly into the assay without enzymatic detachment offers a workflow advantage and potential benefits to cell health and assay performance.” Future studies will include primary cell lines as well as kinase screening, ADME/Tox and live cell assays.

The BioLevitator utilizes the GEM technology, a magnetic culture particle that enables users to pipette transformed, primary and stem cells directly from culture to assay without enzymatic detachment and replating.

Looking forward to the new applications, Uday Gupta, President & CEO of GCS, commented, “We are thrilled to work with BioTek in validating popular cell-based assays using the GEM and BioLevitator. The newly released 3D-CellHOST™ will integrate the BioLevitator on the Hamilton STAR workstation to create a seamless automated workflow for unifying cell culture and cell-based assays.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

BioTek Continues International Growth with Launch of BioTek France
BioTek France team includes Dr. Dirk Frese, Philippe Vivier, Damien Brechet and Lionel Capelle.
Wednesday, January 25, 2012
BioTek Offers Service Through Serlabo in France
Serlabo will provide IQ/OQ/PQ, primary training, service, preventative maintenance and service contracts for users of BioTek's microplate instrumentation.
Friday, January 06, 2012
BioTek Recognized with 5x5x5 Award Again
BioTek receives the Award at the 9th annual awards ceremony on Thursday, September 15, 2011.
Saturday, September 17, 2011
BioTek Welcomes New Product Specialist to Cover Expanding Brazilian Market
BioTek Instruments, Inc. welcomes Marcus Stolarski to the company as Product Specialist. Marcus is responsible for supporting BioTek's distribution network and customers in Brazil.
Thursday, March 10, 2011
BioTek Instruments Announces Establishment of Korean Office
Managed by Mr. Yunki Kyung, the new direct sales and service organization will focus on growing BioTek's brand and expanding direct service and application support for our growing customer base in South Korea.
Tuesday, March 01, 2011
BioTek Announces New Applications and Business Development Manager in Canada
Dr Charles Amirmansour is responsible for supporting BioTek's technical and new business activities with Fisher Scientific Canada.
Monday, February 28, 2011
BioTek’s Synergy H1 Receives HTRF Certification
The latest addition to the patent-pending Hybrid Microplate Reader family has received HTRF® certification from Cisbio Bioassays.
Thursday, September 23, 2010
BioTek Instruments Launches International Web Sites
Company announces the availability of multi-lingual web sites for international customers.
Thursday, July 30, 2009
Introducing Scientifically Speaking - A Microplate Instrumentation Blog by BioTek Scientists
BioTek scientists are reaching out to the online community through their new blog providing general expertise for microplate instrumentation.
Thursday, July 16, 2009
BioTek Instruments Introduces new Web Site
The new web site, that soon will be available in multiple languages, has improved technical and application resources for life science and drug discovery markets.
Wednesday, February 25, 2009
DLReady Certification Awarded for Synergy 2 and Synergy HT Multi-Detection Microplate Readers
The DLR Assay System provides quantitation of firefly and Renilla luciferase reporters in transfected cells.
Wednesday, November 08, 2006
BioTek Delivers Support through Interactive Program
Qualified customers are introduced to the Winooski, VT facility with a brief plant tour.
Tuesday, September 12, 2006
Scientific News
Charting Kidney Cancer Metabolism
Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Honey’s Potential to Save Lives
The healing powers of honey have been known for thousands of years.
3-D Printed Lifelike Liver Tissue for Drug Screening
A team led by engineers at the University of California, San Diego has 3D-printed a tissue that closely mimics the human liver's sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling.
Cytoskeleton Crew
Findings confirm sugar's role in helping cancers survive by changing cellular architecture.
Biomarker for Recurring HPV-Linked Oropharyngeal Cancers
A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University.
Valvena, GSK Sign New R&D Collaboration
Valneva to supply process development services for EB66® -based Influenza vaccines.
Light Signals from Living Cells
Fluorescent protein markers delivered under high pressure.
Cellular 'Relief Valve'
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!